
UK Puberty Blocker Trial Halted Over Safety Fears
The controversial NHS study was suspended after officials warned of “significant” long-term harms.

The controversial NHS study was suspended after officials warned of “significant” long-term harms.

A male doctor identifying as female has left Britain’s health service following a prolonged workplace dispute that became a UK-wide ‘culture war’ debate.

Health service staff are advised not to assume a caller’s gender over the phone, as transgender individuals’ voices may be higher or lower than expected.

Jennifer Melle said she felt “deeply relieved and grateful” for the decision that allows her to return to her clinical duties.

As a person living with treatment-resistant depression, the author asks, “Does the government have the right to determine what qualifies as a ‘good life’?”

Campaigners from across political and cultural divides rallied in Westminster, accusing ministers of pushing ahead with a controversial trial despite safety and consent concerns.

More than 200 children are set to receive drugs in an official clinical trial, which the Reform UK chief calls “state-sponsored child abuse.”

Campaigners argue the study could harm children and question whether research should focus on those who have already taken the treatment.

It will take more than changing the law or government to win back institutions from gender ideologues.

It is not ‘free speech’ to relentlessly ram your political views down the throats of vulnerable sick people lying helpless in a hospital.